Alphacentric Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-12-2024
- Paid Up Capital ₹ 0.13 M
as on 31-12-2024
- Company Age 10 Year, 19 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.60 M
as on 31-12-2024
- Revenue -67.33%
(FY 2023)
- Profit -5861.63%
(FY 2023)
- Ebitda -114.17%
(FY 2023)
- Net Worth -690.87%
(FY 2023)
- Total Assets 24.90%
(FY 2023)
About Alphacentric Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.13 M.
The company currently has active open charges totaling ₹6.60 M.
Vinit Kumar and Bhagyalakshmi Jayanna serve as directors at the Company.
- CIN/LLPIN
U85110KA2014PTC077897
- Company No.
077897
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alphacentric Healthcare Private Limited offer?
Alphacentric Healthcare Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Chocolates, Biscuits & Cookies, Chocolate.
Who are the key members and board of directors at Alphacentric Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinit Kumar  | Whole-Time Director | 28-Aug-2018 | Current |
| Bhagyalakshmi Jayanna | Whole-Time Director | 23-Dec-2014 | Current |
Financial Performance of Alphacentric Healthcare.
Alphacentric Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 67.33% decrease. The company also saw a substantial fall in profitability, with a 5861.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 690.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alphacentric Healthcare?
Unlock access to Alphacentric Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jun 2017 | ₹6.60 M | Open |
How Many Employees Work at Alphacentric Healthcare?
Unlock and access historical data on people associated with Alphacentric Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alphacentric Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alphacentric Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
